CEO sold half his stock!

What the hell?

 

If good new is announced in the next few months, no problem. If bad news is announced, insider trading and shareholder lawsuits are coming.

 

I need to get to daughters lacrosse practice? Really?!

 

As has been said here before,the only people that will make anything on this bottom feeding dead end upside down company will have vp in their title. Why should the ceo selling half his shares surprise you? anyone intelligent here already knows that biosims are D.O.A. in the Us and that we are lead by snakes. We alsoknow that the highest growth rate and sales volume this company will ever achieve is now past. All thats left for us now is the arrival of yet another generic competitor to Neulasta, a2nd rate biosim to an already outdated eye drug, and 5th to market humira or avastin or whatever they have dreamed up. This place is doomed as proven here today by the ceo sell off. Actions speak louder...

 

sold close to 2/3 of his position...nothing alarming there...

“The estimated Net Worth of Dennis M Lanfear is at least $28.4 Million dollars as of 20 November 2019. Mr. Lanfear owns over 825,000 units of Coherus BioSciences stock worth over $8,421,435 and over the last 12 years he sold CHRS stock worth over $16,056,433. In addition, he makes $3,919,780 as Chairman of the Board, President, and Chief Executive Officer at Coherus BioSciences. Dennis has made over 6 trades of the Coherus BioSciences stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 825,000 units of CHRS stock worth $14,850,000 on 20 November 2019.

The largest trade he's ever made was selling 825,000 units of Coherus BioSciences stock on 20 November 2019 worth over $14,850,000. On average, Dennis trades about 38,511 units every 63 days since 2008. As of 20 November 2019 he still owns at least 459,184 units of Coherus BioSciences stock.”

 

Point?

 

Point?You’re the epitome of stupid if you can’t read bw the lines on this.The stock already crested.

 

All this growth and sales performance, but yet still 2/3 of the field will barely make target. Looking forward to seeing who bolts in Jan after the release of s2 bonus. Thompson sucks!

 

What’s in store for 2020? Predictions? Rumors? Discuss......

 

2020? Increased competition, a lower stock price, further spending upon a 2nd rate eye biosimilar, and increased micromanagement as sales erode.

 

MISERY

 

I'm confused. Chris Thompson just told us at the national sales meeting he was going to rain money - why is the stock falling. Guess he is just lying again like when he told us in 2019 in a year our options would be worth 400k. Or Denny saying the true value of the company was 90 dollars a share. Guess leadership is just still full of ****!

 

CEO has no intention of building the company to a triple digit stock. He keeps getting tremendous amount of stock and sells it. All executive level employees stock immediately vests of company is bought. All other employees shares do not vest if company is bought.

 

so , you think the company could be purchased if Toripalimab is approved later this year ??

 

Wish in one hand, and shit in the other. Let us know which fills up first!

 

Coming back baby! We are almost back to 8! Hahahha

 

Almost...

 

You can’t polish a turd.

 

You can't turn chicken shit into chicken salad...